Severe gastritis due to pembrolizumab treatment in a lung cancer patient
Author:
Affiliation:
1. Department of Respiratory Medicine Koto Hospital Tokyo Japan
2. Department of Respiratory Medicine Comprehensive Cancer Center, International Medical Center, Saitama Medical University Saitama Japan
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/rcr2.636
Reference10 articles.
1. Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond
2. An Unusual Case of Gastritis in One Patient Receiving PD-1 Blocking Therapy: Coexisting Immune-Related Gastritis and Cytomegaloviral Infection
3. Severe Gastritis after Administration of Nivolumab and Ipilimumab
4. 2-Deoxy-2-[fluorine-18] fluoro-d-glucose uptake on positron emission tomography is associated with programmed death ligand-1 expression in patients with pulmonary adenocarcinoma
5. Immune‐related adverse events in the gastrointestinal tract: diagnostic utility of upper gastrointestinal biopsies
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Case of Pemrolizumab-Associated Severe Gastritis Treated with Mycophenolate Mofetil;International Journal of Gastroenterology;2024-04-11
2. Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors;Alimentary Pharmacology & Therapeutics;2024-04-08
3. Sintilimab-induced severe erosive hemorrhagic gastritis and pyloric obstruction: a case report and literature review;Immunotherapy;2024-03-26
4. Immune-mediated Gastritis in a Patient with metastatic Lung Cancer due to Therapy with the immune Checkpoint Inhibitor Pembrolizumab – Differences and Similarities in Comparison to “endogenous” autoimmune Type A Gastritis and a review of literature;Zeitschrift für Gastroenterologie;2023-03-24
5. Enhanced In Vitro Cytotoxicity and In Vivo Nursing Care of Gastric Cancer Cells by Nanoparticles Bearing Platinum (IV) Prodrug of Cisplatin;Journal of Biomedical Nanotechnology;2023-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3